MP
Elite in Metastatic Brain Tumor
Check Dr. Marta Penas-Prado's experience treating your condition:
About Dr. Marta Penas-Prado

Marta Penas-Prado is a Neurologist in Houston, Texas. Penas-Prado has been practicing medicine for over 24 years and is rated as an Elite expert by MediFind in the treatment of Metastatic Brain Tumor. She is also highly rated in 19 other conditions, according to our data. Her top areas of expertise are Glioma, Astrocytoma, Glioblastoma, Gliomatosis Cerebri, and Tissue Biopsy. She is licensed to treat patients in Texas.

Her clinical research consists of co-authoring 76 peer reviewed articles and participating in 8 clinical trials in the past 15 years. In particular, she has co-authored 10 articles in the study of Metastatic Brain Tumor.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Marta Penas-Prado it is best to call her office and ask if your insurance is accepted.

Locations
1515 Holcombe Blvd, Houston, TX 77030
Background & Education
Graduate Institution
Other, 1998
Specialties
Neurology
Licenses
Psychiatry & Neurology in TX
Languages Spoken
English
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials

Phase II Trial of the Immune Checkpoint Inhibitor Nivolumab in Patients With Recurrent Select Rare CNS Cancers
Phase I / II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme
Phase 2 Study of VAL-083 Treatment for MGMT Unmethylated Bevacizumab-naïve Glioblastoma in the Adjuvant or Recurrent Setting
A Phase I/II Clinical Trial of Autologous CMV-Specific Cytotoxic T Cells for GBM Patients
A Phase I Lead-In to a 2x2x2 Factorial Trial of Temozolomide, Memantine, Mefloquine, and Metformin as Post-Radiation Adjuvant Therapy of Glioblastoma Multiforme
Phase II Study of Single-agent Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification
Randomized, Double-Blind, Placebo-Controlled Trial of Lacosamide for Seizure Prophylaxis in Patients With High-Grade Gliomas
A Phase II Study of Dose-Dense Temozolomide and Lapatinib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial and Spinal Cord Ependymoma
View 7 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Elite
Distinguished
Distinguished